SRY-negative 46,XX testicular disorder of sex development (de la Chapelle syndrome) presenting with primary infertility: a case report.

Authors

Shubhi Srivastava, Sangita Sharma

Published in

JBRA assisted reproduction. Volume 30. Issue 2. Pages 433-435. Apr 01, 2026.

Abstract

De la Chapelle syndrome describes phenotypic males with a 46,XX karyotype, most commonly caused by translocation of the SRY gene. The SRY-negative variant is exceptionally rare and invariably associated with non-obstructive azoospermia. Awareness of this condition is important for infertility specialists, as genetic evaluation can establish an accurate diagnosis early in the workup and guide appropriate counselling. We report the case of a 30-year-old man who presented with primary infertility. Clinical examination revealed small testes with an otherwise normal male phenotype. Semen analysis confirmed azoospermia, and hormonal testing showed elevated gonadotropins with borderline testosterone levels. Imaging demonstrated reduced testicular volume without malignant features. Karyotype analysis revealed a 46,XX constitution, and molecular testing confirmed the absence of the SRY gene, establishing the diagnosis of SRY-negative de la Chapelle syndrome. Based on these findings, the patient was counselled regarding the futility of autologous sperm retrieval and was advised on donor-assisted reproductive options. Written informed consent was obtained for publication. This case highlights the value of incorporating genetic testing into the evaluation of non-obstructive azoospermia. Early recognition avoids unnecessary invasive interventions such as testicular sperm extraction and allows couples to receive timely counselling about realistic reproductive options. Although natural fertility cannot be achieved, assisted reproduction with donor sperm offers a viable pathway to parenthood. Comprehensive care, including endocrine monitoring, psychosocial support, and multidisciplinary management, ensures optimal outcomes for affected individuals.

PMID:
42330183
Bibliographic data and abstract were imported from PubMed on 23 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.